info.3se@keehealthcare.com

Wrinkles

“The problems with skin aging vary from small lines and “age-spots” to deep wrinkles. The most disliked part of the aging skin is wrinkles. Often given names like the “laugh Lines” or “worry Lines” or the more impressive “bunny line” on the nose, the “nasolabial Folds” on the cheeks and the “Marionette” lines below the lips. With microscopic signs of aging skin are:


Thinning of the epidermis
Degradation of elastic fibers of the dermis with loss of resilience
A zone of abnormally oriented collagen fibers

While gravity is responsible for some signs of skin aging it is the muscle action that produces the wrinkles and the deep facial lines. Skin wrinkles are grooves in the skin, which can be on the surface of the skin or can be quite deep. Wrinkles are the thin, deep, creased, and sagging skin that is especially noticeable on the face, neck, top of the forearms and back of the hands. Wrinkles in turn can be divided into two categories; fine, surface lines and deep furrows. Light wrinkle treatments are very effective for fine lines; whereas deeper creases may require more aggressive techniques. Wind, heat and chemicals and the natural effects of aging cause a certain amount of wrinkling in everyone, but it is much worse in people who spend a lot of time in the sun. The skin begins to sag in places where the collagen, the elastic fibers that support the skin, has weakened the most. The skin around the eyelids, jaw, and neck is especially thin, and therefore more naturally prone to aging. Methods to improve the wrinkles include filling the thinned out skin and depressions, weaken the muscles responsible for the lines, and other techniques stimulate collagen growth


The treatments for wrinkles include Botox®, Fillers, Chemical Peels, Smoothbeam Laser, Medical Microdermabrasion or Surgical Dermabrasion. These treatments may be recommended individually or in combination.”

How it works?

1.

Request for medicine

Patient who has serious problem request for medicine

 

2.

Drug Verify

Internal processing of drug verifications at GM Global

 

3.

Prescription

Recognizing best source for the specific prescription

 

4.

GDP Instruction

Import medicine under the GDP instruction

 

5.

QA check

Supply drugs to concerned healthcare provider after QA check

 

5.

QA check

Supply drugs to concerned healthcare provider after QA check

 

FAQ

A NPP provides access to post-approval drugs that are approved and commercially available in one or more country, other than the patient’s home country.

 

No. Companies are not required to provide their products through a formal NPP.

 

  • Dealing with unsolicited patient request for drug in an ethical and regulatory controlled manner
  • Providing exposure to, and experience with, company products to physicians in additional countries and build a larger KOL network and future advocates
  • Providing new products to patients who would move to commercial drug when it becomes available in these countries
  • Generating additional revenues in countries that allow you to charge for drugs supplied on a named patient basis

Companies can provide drug to patients in any country in which they have not yet received marketing approval. This includes countries in which a company plans to seek marketing approval, as well as those countries in which a company does not plan to seek marketing approval.

 
 

INFORMATION FOR PATIENTS

As a named patient medicines you may find yourself in the frightening position that you have a serious condition or illness and the treatment you need is not available in your home country. It is possible that the medicines are available outside your country and if your physician decides that these drugs would be suitable for the treatment of your illness, they then face the challenge of obtaining them for you. We help physicians across the world access medicines which are not approved or licensed in their country, but may be required to meet the special needs of an individual patient. The service we provide not only locates and supplies the required medicines but ensures that the physician has all the quality assurance and supporting clinical information they will need to safely prescribe it to you. If you are confronted with a situation where a drug is not available to you, talk to your physician or healthcare professional about Named Patient Program and ask them to contact us. We will then work directly with your physician to help them in patient access program and understand what options are available.

 

 

Drugs We Provide Under NPS

Drug Directory

Orphan Drugs

1.

Request for medicine

Patient who has serious problem request for medicine

 

2.

Drug Verify

Internal processing of drug verifications at GM Global

 

3.

Prescription

Recognizing best source for the specific prescription

 

4.

GDP Instruction

Import medicine under the GDP instruction

 

5.

QA check

Supply drugs to concerned healthcare provider after QA check

 

5.

QA check

Supply drugs to concerned healthcare provider after QA check

 

FAQ

A NPP provides access to post-approval drugs that are approved and commercially available in one or more country, other than the patient’s home country.

 

No. Companies are not required to provide their products through a formal NPP.

 

  • Dealing with unsolicited patient request for drug in an ethical and regulatory controlled manner
  • Providing exposure to, and experience with, company products to physicians in additional countries and build a larger KOL network and future advocates
  • Providing new products to patients who would move to commercial drug when it becomes available in these countries
  • Generating additional revenues in countries that allow you to charge for drugs supplied on a named patient basis

Companies can provide drug to patients in any country in which they have not yet received marketing approval. This includes countries in which a company plans to seek marketing approval, as well as those countries in which a company does not plan to seek marketing approval.

 
 

INFORMATION FOR PATIENTS

As a named patient medicines you may find yourself in the frightening position that you have a serious condition or illness and the treatment you need is not available in your home country. It is possible that the medicines are available outside your country and if your physician decides that these drugs would be suitable for the treatment of your illness, they then face the challenge of obtaining them for you. We help physicians across the world access medicines which are not approved or licensed in their country, but may be required to meet the special needs of an individual patient. The service we provide not only locates and supplies the required medicines but ensures that the physician has all the quality assurance and supporting clinical information they will need to safely prescribe it to you. If you are confronted with a situation where a drug is not available to you, talk to your physician or healthcare professional about Named Patient Program and ask them to contact us. We will then work directly with your physician to help them in patient access program and understand what options are available.